Gordon Naylor
Chairman presso MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Patrimonio netto: 567 391 $ in data 31/03/2024
Profilo
Gordon Naylor is currently the Non-Executive Chairman at Medical Developments International Ltd., an Independent Non-Executive Director at Orica Ltd., a Director at Seqirus Holdings UK Ltd., and the Senior Vice President & General Manager at CSL Plasma, Inc. Previously, he served as the Chief Financial Officer at CSL Ltd.
from 2010 to 2016.
He also held positions at CSL Behring LLC and Seqirus UK Ltd., where he was the EVP-Plasma, Supply Chain & Information Systems and the President respectively.
Mr. Naylor obtained an MBA from Melbourne Business School and completed his undergraduate studies at the University of Melbourne.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 07/09/2023 | 950 573 ( 1.10% ) | 372 092 $ | 31/03/2024 | |
ORICA LIMITED
0.00% | 25/03/2024 | 16 394 ( 0.00% ) | 195 299 $ | 31/03/2024 |
Posizioni attive di Gordon Naylor
| Società | Posizione | Inizio |
|---|---|---|
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Chairman | 18/12/2020 |
| ORICA LIMITED | Director/Board Member | 01/04/2022 |
CSL Plasma, Inc.
 CSL Plasma, Inc. Medical/Nursing ServicesHealth Services CSL Plasma, Inc. collects donations of blood plasma in the U.S. through donation centers. The plasma is used by the company's parent to manufacture hemophilia therapies, burns, shock, infection, trauma, and breathing disorders. The company was founded in 2004 and is headquartered in Boca Raton, FL. | Corporate Officer/Principal | - |
Seqirus Holdings UK Ltd.
 Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Part of CSL Ltd., Seqirus Holdings UK Ltd. is an investment holding private company. The company is based in Maidenhead, UK. Seqirus Holdings was founded in 2015. | Director/Board Member | 29/05/2015 |
Precedenti posizioni note di Gordon Naylor
| Società | Posizione | Fine |
|---|---|---|
Seqirus UK Ltd.
 Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Seqirus UK Ltd. manufactures vaccines. Its brands offer include Dukoral, Gardasil, Jespect, Menveo, Panvax, Rabipur, Vaqta, Benpen, Palexia, Rapivab, Tramal, and Versatis. The company was founded on July 31, 2015 and is headquartered in Maidenhead, the United Kingdom. | President | 01/06/2019 |
| CSL LIMITED | Director of Finance/CFO | 02/01/2016 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Director of Finance/CFO | - |
Formazione di Gordon Naylor
| Melbourne Business School | Masters Business Admin |
| University of Melbourne | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CSL LIMITED | Health Technology |
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Health Technology |
| ORICA LIMITED | Process Industries |
| Aziende private | 4 |
|---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
CSL Plasma, Inc.
CSL Plasma, Inc. Medical/Nursing ServicesHealth Services CSL Plasma, Inc. collects donations of blood plasma in the U.S. through donation centers. The plasma is used by the company's parent to manufacture hemophilia therapies, burns, shock, infection, trauma, and breathing disorders. The company was founded in 2004 and is headquartered in Boca Raton, FL. | Health Services |
Seqirus UK Ltd.
Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Seqirus UK Ltd. manufactures vaccines. Its brands offer include Dukoral, Gardasil, Jespect, Menveo, Panvax, Rabipur, Vaqta, Benpen, Palexia, Rapivab, Tramal, and Versatis. The company was founded on July 31, 2015 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Seqirus Holdings UK Ltd.
Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Part of CSL Ltd., Seqirus Holdings UK Ltd. is an investment holding private company. The company is based in Maidenhead, UK. Seqirus Holdings was founded in 2015. | Finance |
- Borsa valori
- Insiders
- Gordon Naylor
